Recurrent septicemia in an immunocompromised patient due to probiotic strains of Bacillus subtilis.
作者信息
Oggioni M R, Pozzi G, Valensin P E, Galieni P, Bigazzi C
出版信息
J Clin Microbiol. 1998 Jan;36(1):325-6. doi: 10.1128/JCM.36.1.325-326.1998.
Abstract
摘要
相似文献
1
Recurrent septicemia in an immunocompromised patient due to probiotic strains of Bacillus subtilis.
J Clin Microbiol. 1998 Jan;36(1):325-6. doi: 10.1128/JCM.36.1.325-326.1998.
2
[Bacteremia Due to Bacillus subtilis: A Case Report and Clinical Evaluation of 10 Cases].
Kansenshogaku Zasshi. 2017 Mar;91(2):151-4.
3
Antimicrobial Peptidomimetics for Recurrent Septicemia Infections: In Vitro Study for Immuno Compromised Disease Target.
Drug Res (Stuttg). 2018 Sep;68(9):499-503. doi: 10.1055/s-0043-119069. Epub 2018 Apr 16.
4
Recurrent Achromobacter piechaudii bacteremia in a patient with hematological malignancy.
J Clin Microbiol. 2001 Feb;39(2):808-10. doi: 10.1128/JCM.39.2.808-810.2001.
5
Recurrent bacteremia due to Brevibacterium casei in an immunocompromised patient.
Eur J Clin Microbiol Infect Dis. 1995 Dec;14(12):1082-5. doi: 10.1007/BF01590943.
6
Fulminant septicemic syndrome of Bacillus cereus in a leukemic patient.
Intern Med. 1997 Mar;36(3):221-6. doi: 10.2169/internalmedicine.36.221.
7
Combined Bacillus licheniformis and Bacillus subtilis infection in a patient with oesophageal perforation.
J Med Microbiol. 2012 Dec;61(Pt 12):1766-1769. doi: 10.1099/jmm.0.042275-0. Epub 2012 Aug 23.
8
Bacillus subtilis septicemia and generalized aspergillosis in a patient with acute myeloblastic leukemia.
N Y State J Med. 1958 Jun 1;58(11):1870-6.
9
Bacillus subtilis septicemia: report of two cases.
J Okla State Med Assoc. 1971 Aug;64(8):350-2.
10
Septicemia caused by dysgonic fermenter 3 in a severely immunocompromised patient and isolation of the same microorganism from a stool specimen.
J Clin Microbiol. 1999 May;37(5):1617-8. doi: 10.1128/JCM.37.5.1617-1618.1999.
引用本文的文献
1
Genomic Investigation of a Bacillus subtilis Strain Sourced from Commercially Available Milk Powder in China Reveals Potential Risk Factors.
Infect Drug Resist. 2025 Aug 25;18:4311-4328. doi: 10.2147/IDR.S544153. eCollection 2025.
2
Antibiotic Resistance Gene Expression in Veterinary Probiotics: Two Sides of the Coin.
Vet Sci. 2025 Mar 2;12(3):217. doi: 10.3390/vetsci12030217.
3
Selection, Comparative Genomics, and Potential Probiotic Features of Escherichia coli 5C, a pks-Negative Strain Isolated from Healthy Infant Donor Feces.
Probiotics Antimicrob Proteins. 2025 Apr 16. doi: 10.1007/s12602-025-10522-5.
4
Effects of probiotic treatment on the prognosis of patients with sepsis: a systematic review.
World J Emerg Med. 2025;16(1):18-27. doi: 10.5847/wjem.j.1920-8642.2025.018.
5
Biofilm-based biocatalysis for β-cyclodextrin production by the surface-display of β-cyclodextrin glycosyltransferase in Bacillus subtilis.
Sci Rep. 2024 Dec 2;14(1):29925. doi: 10.1038/s41598-024-81490-z.
6
Probiotics and Prebiotics for the Treatment of Irritable Bowel Syndrome-A Narrative Review.
J Clin Med. 2024 Oct 23;13(21):6337. doi: 10.3390/jcm13216337.
7
Benefits and concerns of probiotics: an overview of the potential genotoxicity of the colibactin-producing Nissle 1917 strain.
Gut Microbes. 2024 Jan-Dec;16(1):2397874. doi: 10.1080/19490976.2024.2397874. Epub 2024 Sep 4.
8
Comprehensive Metagenomic Analysis of Veterinary Probiotics in Broiler Chickens.
Animals (Basel). 2024 Jun 29;14(13):1927. doi: 10.3390/ani14131927.
9
A case of community-acquired pneumonia caused by subsp. in an immunocompetent patient.
Respirol Case Rep. 2024 May 14;12(5):e01384. doi: 10.1002/rcr2.1384. eCollection 2024 May.
10
Recurrent Bacillus subtilis Var. Natto Bacteremia and Review of the Literature on Bacillus subtilis: The First Case Report.
Am J Case Rep. 2024 Feb 9;25:e942553. doi: 10.12659/AJCR.942553.
本文引用的文献
1
Bacillus subtilis as a cause of cholangitis in polycystic kidney and liver disease.
Am J Gastroenterol. 1996 Jul;91(7):1477-8.
2
Antibiotic susceptibility as a taxonomic characteristic of the genus Bacillus.
Int J Syst Bacteriol. 1995 Apr;45(2):409-11. doi: 10.1099/00207713-45-2-409.
3
Determination of the spectrum of antibiotic resistance of the "Bacillus subtilis" strains of Enterogermina.
Chemioterapia. 1984 Feb;3(1):45-52.
4
Nosocomial bacteremia caused by Bacillus species.
Eur J Clin Microbiol Infect Dis. 1988 Dec;7(6):783-5. doi: 10.1007/BF01975049.
5
[Bacillus subtilis infections].
Schweiz Rundsch Med Prax. 1988 Nov 8;77(45):1219-23.
6
Atypical meningitis complicating a penetrating head injury.
J Neurol Neurosurg Psychiatry. 1991 Jan;54(1):92-3. doi: 10.1136/jnnp.54.1.92-a.
7
On the safety of Bacillus subtilis and B. amyloliquefaciens: a review.
Appl Microbiol Biotechnol. 1991 Oct;36(1):1-4. doi: 10.1007/BF00164689.
8
"Bacillus subtilis" infection in a patient submitted to a bone marrow transplantation.
Rev Paul Med. 1992 May-Jun;110(3):116-7.
9
Studies on the antibiotic resistance of Bacillus subtilis strains used in oral bacteriotherapy.
Boll Chim Farm. 1992 Dec;131(11):401-8.
Zotero 插件